Deutsche Bank Aktiengesellschaft »

Cartesian Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2025-09-30 $76k 7.4k 10.22
2025-06-30 $77k 7.4k 10.39
2025-03-31 $98k 7.4k 13.18
2024-12-31 $65k 3.6k 17.91
2024-09-30 $59k 3.6k 16.12
2024-06-30 $98k 3.6k 27.01